Morning mooers! It is Friday, April 5th, and I just felt an earthquake in Jersey City. The market is shaking from hot jobs data released by the Bureau of Labor Statistics. The economy added 303k jobs in March, nearly 100k more than expected. My name is Kevin Travers, here are your morning moovers today: MOOVERS $General Electricwas the biggest gainer of the S&P after the firm successfully spun off GE Vernova. $Enphase Energywas the biggest loser ...
gkoval172 :
Yeah, the correlation between high employment and high inflation still has me hesitant at the moment. Sitting on cash until a larger pullback
Morning Movers Gapping up $ショックウェーブ メディカル(SWAV.US)$stock rose 1.6% after Johnson & Johnson announced it would buy the company for $12.5 billion. The transaction would boost J&J’s portfolio of cardiovascular disease treatment devices. $クリスピークリーム(DNUT.US)$stock rose 5.3% after Piper Sandler upgraded its stance on the doughnut chain to 'overweight' from 'neutral’, saying its national partnership with McDonald’s (NYSE:MCD) could...
Morning Movers Gapping up $ドイチェ バンク(DB.US)$shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024. $メルク(MRK.US)$stock rose 4.8% after its drug for treating a rare lung disease received FDA approval. $トランプ・メディア・アンド・テクノロジー・グループ・コーポレーション(DJT.US)$stock jumped 14%, following gains after its Nasdaq debut. $ロビンフッド マーケッツ A(HOOD.US)$stock climbed 6...
Shockwave Medical's profitability and reinvestment in its business is a positive sign. The stock's exceptional performance over the last five years is worth investigating. However, investors should be aware of the associated risks with the company.
Insider sale at current price of US$261 at Shockwave Medical is not alarming but not positive either. High insider ownership usually benefits all shareholders, but past share sales cause hesitation. Investors should note 3 warning signs.
Shockwave CEO, Doug Godshall, is excited about Gaeta's appointment and anticipates the company's next growth phase. Gaeta is also enthusiastic about joining Shockwave and contributing to its mission with breakthrough technologies.
Shockwave Medical's high P/E ratio is alarming due to its weak earnings forecast and slower market growth. Investors may face disappointment if the P/E aligns with the growth outlook, risking significant investments and potential overpayment.
Shockwave Medical's emergence into profitability and reinvestment into its business indicate promising long-term value growth trends. However, potential investors should further research these trends and be vigilant of any warning signs tied to the company.
The absence of recent insider buying combined with high volume insider selling in the last year at Shockwave Medical doesn't offer much positive encouragement. The level of insider ownership, while not exceptional, does suggest some degree of alignment with shareholders.
ショックウェーブ メディカルに関するコメント
TuHURA Biosciences merger w/ $キンタラ セラピューティクス(KTRA.US)$
$ジョンソン エンド ジョンソン(JNJ.US)$ to acquire $ショックウェーブ メディカル(SWAV.US)$
$バーテックス ファーマシューティカルズ(VRTX.US)$ to acquire $アルパイン イミューン サイエンシズ(ALPN.US)$
What companies will be next? 🤔
My name is Kevin Travers, here are your morning moovers today:
MOOVERS
$General Electric was the biggest gainer of the S&P after the firm successfully spun off GE Vernova.
$Enphase Energy was the biggest loser ...
Gapping up
$ショックウェーブ メディカル(SWAV.US)$ stock rose 1.6% after Johnson & Johnson announced it would buy the company for $12.5 billion. The transaction would boost J&J’s portfolio of cardiovascular disease treatment devices.
$クリスピークリーム(DNUT.US)$ stock rose 5.3% after Piper Sandler upgraded its stance on the doughnut chain to 'overweight' from 'neutral’, saying its national partnership with McDonald’s (NYSE:MCD) could...
Gapping up
$ドイチェ バンク(DB.US)$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$メルク(MRK.US)$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$トランプ・メディア・アンド・テクノロジー・グループ・コーポレーション(DJT.US)$ stock jumped 14%, following gains after its Nasdaq debut.
$ロビンフッド マーケッツ A(HOOD.US)$ stock climbed 6...
まだコメントはありません